Guidelines for Biomedical HIV Prevention Trials
These Good participatory practice guidelines for biomedical HIV prevention rials will be of use to civil society groups in their advocacy for well conducted clinical trials. Although not addressed specifi cally, those engaged in trials of new therapeutics, such as antiretroviral medications or treating HIV-related disease, or in HIV prevention trials assessing behavioural or other HIV prevention modalities may find them relevant.
| Attachment | Size |
|---|---|
| 2008 02 11 Biomedical Research Best Practices.pdf | 733.22 KB |
